Cargando…
Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC)
Congestive heart failure (HF) is a morbidity that is increasing worldwide due to the aging population and improvement in (acute) care for patients with cardiovascular diseases. The prognosis for patients with HF is very poor without treatment. Furthermore, (repeated) hospitalizations for cardiac dec...
Autores principales: | Berliner, Dominik, Bauersachs, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614938/ https://www.ncbi.nlm.nih.gov/pubmed/28955380 http://dx.doi.org/10.4070/kcj.2017.0030 |
Ejemplares similares
-
Adherence to the European Society of Cardiology (ESC) guidelines for chronic heart failure - A national survey of the cardiologists in Pakistan
por: Shoukat, Sana, et al.
Publicado: (2011) -
New drugs: big changes in conservative heart failure therapy?
por: Berliner, Dominik, et al.
Publicado: (2019) -
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
por: Meijers, Wouter C., et al.
Publicado: (2021) -
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension
Publicado: (2007) -
The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC
por: Frantz, Stefan, et al.
Publicado: (2018)